Surmodics, Inc.
SRDX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $26 | $29 | $30 | $36 |
| Short-Term Investments | $6 | $2 | $0 | $4 |
| Receivables | $25 | $21 | $23 | $23 |
| Inventory | $16 | $16 | $15 | $15 |
| Other Curr. Assets | $2 | $3 | $4 | $3 |
| Total Curr. Assets | $76 | $72 | $72 | $81 |
| Property Plant & Equip (Net) | $23 | $26 | $24 | $28 |
| Goodwill | $46 | $44 | $42 | $45 |
| Intangibles | $22 | $21 | $21 | $24 |
| Long-Term Investments | $0 | $0 | $1 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $1 | $4 | $1 |
| Total NC Assets | $94 | $91 | $92 | $97 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $170 | $163 | $164 | $179 |
| Liabilities | – | – | – | – |
| Payables | $6 | $3 | $3 | $3 |
| Short-Term Debt | $1 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $2 | $1 |
| Deferred Revenue | $1 | $0 | $0 | $2 |
| Other Curr. Liab. | $12 | $8 | $6 | $16 |
| Total Curr. Liab. | $19 | $14 | $13 | $21 |
| LT Debt | $32 | $32 | $32 | $32 |
| Deferred Rev, NC | $2 | $0 | $0 | $3 |
| Deferred Tax Liab, NC | $2 | $2 | $2 | $2 |
| Other NC Liab. | $1 | $6 | $5 | $2 |
| Total NC Liab. | $39 | $39 | $39 | $39 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $3 | $3 | $4 |
| Total Liabilities | $59 | $53 | $52 | $60 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | $62 | $67 | $72 | $76 |
| AOCI | $1 | -$4 | -$6 | -$2 |
| Other Equity | $48 | $47 | $45 | $45 |
| Total Equity | $111 | $110 | $112 | $119 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $170 | $163 | $164 | $179 |
| Net Debt | $6 | $5 | $4 | -$2 |